Medicare beneficiaries using lower-priced negotiated drugs experienced out-of-pocket savings under the Medicare Drug Price ...

A brief research report found that Medicare beneficiaries taking several commonly prescribed medications could see ...

This month’s issue of Health Affairs features a wide variety of content. We lead the issue with a pair of articles that look at insurer-provider negotiations: one regarding “brinkmanship” in hospital ...

At the end of the last article, I wrote this to you: "Even by cutting down business hours with a template, I was still one ...

This year's drug price negotiation period ends Nov. 1, with the first price offers coming June 1. (Getty Images/twilightproductions) Spring has nearly sprung, and round two of the Inflation Reduction ...

"How much is the brokerage fee?"—you have already lost before this question is even asked. Have you ever had these words ...

Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

Botox and the GLP-1 drug Trulicity are among the latest group of prescription drugs subject to price controls by Medicare. The Centers for Medicare & Medicaid Services (CMS), the federal agency that ...

The Medicare Drug Price Negotiation Program survived an attempt to nullify it on Aug. 26 as a federal appeals court unanimously rejected a constitutional challenge to the program’s validity. The case ...

The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...